CA2712040A1 — Behavior modification with intermittent reward
Assigned to Healthhonors Corp · Expires 2008-07-24 · 18y expired
What this patent protects
The invention relates to simple yet effective methods, referred to herein as Dynamic Intermittent Reward (DIR), and systems, to increase the frequency of a desired behavior in a user, and optimize cost-effectiveness of a reward system. A principal benefit of the new methods is th…
USPTO Abstract
The invention relates to simple yet effective methods, referred to herein as Dynamic Intermittent Reward (DIR), and systems, to increase the frequency of a desired behavior in a user, and optimize cost-effectiveness of a reward system. A principal benefit of the new methods is the ability to provide tailored intermittent rewards for one or more users over time. The invention further relates to other methods, referred to herein as Tabular Intermittent Reward (TIR), and systems, to administer intermittent rewards without an element of chance.
Drugs covered by this patent
- Abilify (aripiprazole) · Generic (originally Otsuka/BMS)
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.